Much ado about nothing? Recent FDA alerts and NovoNordisk lawsuits
Due to the blockbuster weight loss drugs Ozempic, Wegovy and Mounjaro going on the FDA Shortage List, compounding pharmacies are legally allowed to make duplicates of these name brand drugs without risk of patent infringement. And even though NovoNordisk, the maker of Ozempic and Wegovy, admits they can’t keep up with demand, they’re trying everything […]
Shame on you Mississippi and West Virginia
Why would Mississippi and West Virginia, states that are ranked #1 and #4 in poverty, #5 and #1 in adult obesity, and #2 and #4 in adolescent obesity, respectively, eliminate access to the most affordable version of the safe and effective weight loss drugs Ozempic and Wegovy? Background on Ozempic and Wegovy Not since […]
Consumers’ misguided focus on the risks surrounding Ozempic and Wegovy
Consumers reluctant to try new weight loss drugs seem to focus more on the least likely risks such as pancreatitis and a rare type of thyroid cancer rather than focusing on the more common side effects like burping, nausea, vomiting, constipation and diarrhea. Instead of focusing on the risks associated with taking the medication, patients […]
Automating your weight management (or any recurring subscription) program
Recently, our office posted a video on TikTok weighing in on whether a celebrity lost weight by diet, exercise and/or the use of the groundbreaking weight loss medication, semaglutide, the active ingredient in Ozempic (approved for type 2 diabetes in 2017) and Wegovy (approved for obesity in 2021) . It was a topic that our […]
10 Reasons Every Practice Should Add a Weight Management Program
1. Increase your patient base: Adding a weight management program to an aesthetic practice can help attract a new population of patients who are looking to improve their appearance and health through weight management. If your current practice offers weight loss surgery, then you already realize not every potential patient is a good candidate right […]